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Abstract: We investigated whether the transplantation of neurotrophin-3 gene transfected mesenchymal stem cells
(NT-3-MSC) could promote hind limb functional recovery and axonal outgrowth in a model of spinal cord injury.
We found that NT3-MSC transplantation in the contused spinal cord significantly improved hind limb function,
axonal outgrowth, and MSC survival, suggesting that gene therapy combined with MSC treatment may represent a
useful strategy for treatment of spinal cord injury.
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1. Introduction
Several therapeutic strategies have been developed to
promote functional recovery and axonal outgrowth after spinal
cord injury (SCI). The application of neurotrophic factors, such
as the neutrophins, has been shown to improve axonal
outgrowth after injury.
1-5
Recent studies have reported that mesenchymal stem cells
(MSCs) promote some functional recovery after grafting into
sites of injury in the spinal cord.
6-9 Grafted MSCs that survived
in the site of injury formed cell bridges in the resulting cavity.
The transplantation of genetically modified cells expressing
neurotrophic factors has been investigated as a method to
improve axonal regeneration after SCI.
10-12 Neurotrophin (NT-
3)-engineered fibroblasts applied acutely
13 and chronically14 to
lumbar motoneurons showed improvement in the intracellular
recorded synaptic response. Transplanted NT-3 expressing
mesenchymal stem cells (NT3-MSCs) have been shown to
increase axonal growth in a model of spinal cord injury.
15
In this study we investigated whether the transplantation of
NT3-MSCs after a spinal cord contusion injury promoted hind
limb function and axonal outgrowth, possibly offering gene
therapy with MSCs as a future treatment paradigm.
2. Materials and Methods
2.1 Separation and Culture of MSC
Approximately 5 ml of bone marrow aspirates, recovered
from human iliac crest during bone marrow harvesting for
future allografic transplantation, were centrifuged through a
density gradient for 30 minutes at 400 g. Cells were plated in
100 mm dishes containing DMEM supplemented with
10%FBS, 100 units/ml of penicllin, and 100 µg/ml of
streptomycin (Gibco BRL). When the cells reached confluency,
they were detached using 0.25% trypsin and 0.02% EDTA in
PBS. Cells were then passed 3-4 times in all experiments.
MSCs were infected with either a GFP adenovirus (100 MOI)
or NT-3-GFP adenovirus (100 MOI), with approximately 3,000
cells/cm
2 plated and maintained overnight.
2.2 Construction of NT3-Ad and Transfection of MSC
The NT3 coding sequence was amplified from rat brain tissue
by RT-PCR using the primers 5'gctggtaccatgtccacatcaacatc3' and
5'tcggatccttaatgcttgtagaagct3'. Rat NT3 cDNA was sub-cloned
into pShuttle-IREShrGFP2 between the CMV early promoter
and the SV40 polyadenylation site using the NotI and SalI sites.
The subsequent clone was transformed into E. coli BJ-5183,
along with pAdeasy1, to recombine NT3 cDNA with the
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adenoviral genome according to the manufacturer’s instruction
(Stratagen). Recombinant DNA was then transfected into 293
cells for adenovirus generation. Viruses from a single plaque
were amplified in 293 cells, and viral stocks were formed by the
repeated freezing and thawing of cells prior to ultrasonication.
Viral stocks were kept in aliquots at -80
oC until use.
2.3 Spinal Cord Injury
Male Sprague-Dawley rats (Daehan Biolink, Chungbuk,
Korea), weighing 300-350 g, were used. All animal
experiments were approved by the Animal Care and Use
Committee of Yonsei University College of Medicine. Animals
were anesthetized using sodium pentobarbital (20 mg/kg),
followed by the contusion at the T9 level of the spinal cord
using the NYU weight-drop device, producing a moderately
contused spinal cord injury model.
2.4 Transplantation of MSC
For the transplantation study, animals were randomly
assigned to one of three groups: the media treatment group, the
MSC treatment group, and the NT3-MSC treatment group (n=8
for each group). A week after spinal cord contusion, using an
electrode microneedle, 5 µl (1×10
5 cells/µl) of MSCs, NT3-
MSCs, or media were injected through a small hole in the dura
into the lesion space. All animals daily received Cyclosporine
A (10 mg/kg) for 8 weeks after transplantation.
 
2.5 Behavioral Assessment After SCI
To measure functional recovery of the hind limbs, each
animal was tested as previously described.
16 Briefly, rats were
placed into an open field and allowed to adapt. Once a rat
walked continuously, two examiners conducted a 5 minute, pre-
operative testing session using the BBB locomotor rating scale.
Post-operative (p.o.) open-field testing was carried out at least
once a week for 8 weeks after experimental treatment.
2.6 Immunohistochemistry
To evaluate the cellular characteristics of the transplanted
cells in vivo, immunhistochemical analysis was performed.
Eight weeks after experimental treatment, rats were perfused
with PBS and 4% paraformaldehyde (PFA). Spinal cords were
removed and fixed in 4% PFA for 4 hours, followed by overnight
submersion in 30% sucrose in PBS. Serial, longitudinal sections
of the spinal cord were obtained using the cryostat (12 µm
thick; Microm/HM500V, CE, Germany). The following day,
sections were fixed with 4% PFA for 10-15 minutes and rinsed
with PBS. Sections were blocked for 1 hour at room
temperature, followed by primary anti-body exposure, which
consisted of anti-GFP (1:500, Chemicon), anti-human specific
mitochondria (1:50, Chemichon), anti-neurofilament (1:1000,
DAKO), and anti-VEGF (1:50, Chemicon). Texas red (1:250,
vector) or FITC (1:250, vector) was applied as the secondary
anti-body for one hour. Sections were then mounted on slides
using fluorescent mounting medium (Vectorshield, Vector,
USA), followed by observation under a florescence microscope
(BX51, Olympus, Tokyo, Japans) or confocal microscope
(LSM 510, Zeiss, Germany).
2.7 Real-Time Polymerase Chain Reaction (RT-PCR)
To measure NT-3 in vivo, real-time PCR was performed
using the 7500 real-time PCR system (Applied Biosystems,
Cheshire, UK) 1 week after transplantation (n=3 for each
group). Twenty microliters of reaction solution (12.5 ng of
cDNA, 0.5 µM reverse primer, and SYBR green PCR master
Figure 1. MSCs transplanted into the injured spinal cord. (A)
Adenovirus GFP was introduced into MSC. The number of GFP
expressing-MSC increased with MOI dependently. (B) Double
staining for human mitochondria and GFP was performed at 8
weeks after transplantation. The number of human mitochondria-
positive cells was greater in NT-3-MSC transplanted group.
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mix) were used for PCR as follows: 50oC for 2min, 95oC for
10min, and 45cycle for 15s at 95
oC and 1min at 55oC. The
following primers were used (NT-3: forward primer, 5´-CTC
CCT GCT CTG GTT CTC TG -3'; reverse primer, 5´-CCA
GGC GGA TAT CTT GAA AA-3'. For GAPDH: forward
primer, 5´-AAG GGC TCA TGA CCA CAG TC -3´; reverse
primer, 5´-GGA TGC AGG GAT GAT GTT CT -3´).
2.8 Statistical Analysis
Data are expressed as mean±standard error. One-way
ANOVA followed by Dunnett’s post-hoc multiple comparison
tests was conducted to determine statistical differences between
MSC, NT3-MSC, and media-treated groups.
3. Results
3.1 Transplanted MSCs 
MSCs were transfected with adenovirus GFP or NT3-GFP.
GFP expression was observed using a fluorescence
microscope. Infection efficiency increased MOI in a dependent
manner (Fig 1A). About 50% of all cells were transfected at
100 MOI. To confirm the existence of transplanted MSCs,
surviving MSCs were visualized through human mitochondria
and GFP staining 8 weeks after transplantation (Fig 1B).
Immunoreactivity to human-specific mitochondria antibodies
was observed in the site of injury, indicating the mesenchymal
stem cell transplantations were successfully grafted into the
lesion site after transplantation. MSC survival was increased in
the NT3-MSC transplanted group compared to the MSC group.
3.2 Expression of NT-3 and Vascular Endothelial Cell
Growth Factor (VEGF)
One week after transplantation, NT-3 expression was
measured in normal, untreated injured, MSC transplanted, and
NT3-MSC transplanted rats (Fig 2A). NT-3 expression in the
MSC group, when compared to the untreated (media injected)
group, was not significant, but also it was not showed the
consistent expression pattern. In contrast, NT-3 expression in
NT3-MSC transplanted animals was higher than in the media
control groups (p < 0.01), it’s consistently showed the high
expression level compare with MSC group. To confirm
whether injected MSCs can express other growth factors,
double-staining with anti-GFP and vascular endothelial cell
growth factor (VEGF) was performed, confirming that MSCs
transplanted into the injured spinal cord indeed express VEGF.
3.3 Axonal Outgrowth and Tissue Restoration
To investigate whether NT3-MSC tranplants could improve
axonal growth, anti-neurofilament (NF) immunostaining was
performed 8 weeks after transplantation (Fig 3A). While axonal
outgrowth in the MSC transplanted group was greater than the
media injected group, such growth was more prominent in the
NT3-MSC transplanted group. In addition, cavity formation
was routinely observed in the media treated group, whereas the
incidences of cavity sightings were lower in the groups that
received cell transplants.
3.4 Behavior Tests
Animals with low scores and correspondingly paretic hind
Figure 2. Expression of NT-3 and VEGF after transplantation. (A) NT-3 expression was confirmed by real time PCR one week after
transplantation. NT-3 expression in NT-3-MSC was significantly greater than that of the media injected group. NT-3 expression in NT-3-
MSC consistently increased over time compared to NT-3 expression in MSCs. *:significant difference compare to media group
(ANOVA, p < 0.05). Data are shown as mean±SD. (B) Expression of the endogenous growth factor one week after transplantation.
MSCs were well grafted into the injured spinal cord, and transplanted MSCs also expressed endogenous VEGF. Scale bar= 20 um.
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limbs were selected for experimentation. The media treated
group (n=8) had a score of 2 in both legs one day after injury,
with the scores gradually increasing over the course of 8 weeks
after treatment. In contrast, just one week after treatment, the
MSC (n=8) and NT3-MSC (n=8) transplanted groups exhibited
improved hind limb performance when compared to the media
controlled group. From 5 weeks after transplantation onward,
the NT3-MSC transplanted group showed significant hind limb
improvement over the MSC treated group (p < 0.05).
4. Discussion
Mesenchymal stem cells have been shown to have positive
effects in the environment of the injured spinal cord. NT-3, a
growth factor that has been shown to enhance the sprouting of
injured axons, has potential to positively affect long tract
regeneration in the injured spinal cord15 and cell survival.17 As
such, the combination of MSCs with NT-3 delivery provides an
attractive method for treating the injured spinal cord.
In this study, we showed that the transplantation of MSCs or
NT3-MSCs into the contused spinal cord could facilitate the
promotion of functional improvement. Previous reports suggest
that MSCs promote functional recovery when grafted in spinal
cord contusion models.7-9,18 As we report, hind limb performance
in the present experiment was modestly improved in cell
transplanted groups. Using immunohistochemistry, human-
specific mitochondria-positive cells were observed in as well as
around the injury epicenter, raising the idea that MSCs may
migrate short distances from the epicenter into host tissue.
11
Transplanted cell survival was more profound in the NT3-MSC
group than in the MSC group, reinforcing the understanding that
NT-3 has a neurotrophic effect
17, it can reasonably be explained
that the presence of NT-3 allowed for the MSCs to survival
longer in the hostile environment present in SCI. While one
study demonstrated that transplantation of NT3-MSCs into the
injured spinal cord led to neuronal differentiation in vitro,19 we
did not observe this phenomenon in either of the cell transplanted
groups.
Analyzing the PCR result, there was no significant difference
in the expression of NT-3 between the NT3-MSC and MSC
transplanted groups one week after treatment. However, NT-3
expression in GFP-MSCs (control) was not significant
compared to the PBS group, also NT-3 expression was not
consistently increased. In contrast, NT-3 expression was
consistently high in the NT3-MSC transplanted group over the
course of the experiment. Yet, it showed a similar pattern of
increase as seen in the control GFP-MSC group. This leads us
to think that the increase in functional recovery and axonal
outgrowth is consistent with increased NT-3 expression.
In a previous study of ours, we confirmed that MSCs can
Figure 3. Axonal outgrowth, tissue restoration, and functional recovery (A) Transplantation with MSC or NT-3-MSC showed better tis-
sue restoration compare with media treatment. Specifically, NT-3-MSC transplantation was associated with greater axonal outgrowth 8
weeks after treatment. (*:cavity formation) (B) Transplantation with MSC or NT-3-MSC improved hind limb performance compared
with that of media treatment, an effect present from one week after transplantation. Functional recovery in the NT-3-MSC transplanta-
tion group significantly improved compared to the MSC transplanted from 5 weeks after treatment. (↑:transplantation time; †:significant
difference compare with both MSC and Media group, p < 0.05; *:significant difference compare with media group, p < 0.05). Data are
shown as mean±SEM.
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secrete paracrine factors such as VEGF,20 and that such factors
may contribute to neural protection.
21,22 In this study, MSCs
transplanted into the site of injury exhibited VEGF expression,
pointing toward the idea that paracrine factor release by MSCs
possibly accelerates functional improvement.
5. Conclusion
In this study, the transplantation of NT3-MSCs into the spinal
cord after contusion injury greatly improved functional
outcome and axonal outgrowth. MSCs may represent a useful
resource for combinatorial approaches to SCI repair, including
ex vivo gene therapy.
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